In this view, emerging findings suggest that besides the strong anti-inflammatory activity, ocrelizumab may contribute to limiting disability progression and may exert beneficial effects on cognitive function, fatigue, and quality of life of MS patients
[1] [2] It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a naturally occurring hormone that regulates appetite and food intake
Many healthcare providers recommend starting with a lower dose and gradually increasing it to help minimize these effects
3) in CA1 hippocampus [33, 34] just like diazepam and zolpidem
The medullary collecting tubule becomes the medullary collecting ducts which merge to form progressively larger ducts that eventually empty the resulting urine into the renal pelvis through the renal papillae
If headaches persist or significantly affect your quality of life, talk to your healthcare provider